Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transient monocular visual loss.

Amy Amick1, Louis R Caplan

  • 1Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. aamick@bidmc.harvard.edu

Comprehensive Ophthalmology Update
|June 2, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Locked-in syndrome.

Handbook of clinical neurology·2026
Same author

Transient ischemic attack in the twenty first century: is it still a useful construct?

Frontiers in stroke·2026
Same author

Risk of major vascular events in patients without traditional risk factors after transient ischemic attack or minor ischemic stroke: An international prospective cohort.

European stroke journal·2024
Same author

Time Windows Between Symptom Onset and Treatment-An Outdated Myth.

JAMA neurology·2024
Same author

Frequency of Intubation for Medicare Beneficiaries With Acute Stroke and Association With Patient Outcomes.

Neurology·2024
Same author

Underlying Causes of TIA and Minor Ischemic Stroke and Risk of Major Vascular Events.

JAMA neurology·2023
Same journal

Persistent corneal ulcer.

Comprehensive ophthalmology update·2008
Same journal

Gonioscopy.org: a video Atlas.

Comprehensive ophthalmology update·2008
Same journal

Pay for performance: is it ethical?

Comprehensive ophthalmology update·2008
Same journal

Review of sulfonamide-induced acute myopia and acute bilateral angle-closure glaucoma.

Comprehensive ophthalmology update·2008
Same journal

Intravitreal pharmacotherapy: applications in retinal disease.

Comprehensive ophthalmology update·2008
Same journal

Comments on: management of proliferative diabetic retinopathy.

Comprehensive ophthalmology update·2008
See all related articles

Transient monocular visual loss stems from various eye and systemic issues. Identifying the cause, often embolic occlusions, is crucial for effective management and preventing vision loss.

Area of Science:

  • Ophthalmology
  • Neurology
  • Vascular Medicine

Background:

  • Transient monocular visual loss (TMVL) presents a diagnostic challenge due to diverse underlying etiologies.
  • Embolic events originating from the heart, aorta, and carotid arteries are significant contributors to TMVL.
  • Other causes include retinal vasoconstriction, anterior ischemic optic neuropathy, papilledema, and intrinsic ocular conditions.

Purpose of the Study:

  • To review the various causes of transient monocular visual loss.
  • To emphasize the importance of identifying the specific etiology for appropriate management.
  • To discuss the common embolic substances implicated in ocular artery occlusions.

Main Methods:

  • Literature review of ophthalmic and systemic conditions causing transient monocular visual loss.

Related Experiment Videos

  • Analysis of the origins and composition of emboli affecting ocular circulation.
  • Discussion of differential diagnoses including retinal vasoconstriction and optic neuropathies.

    • Main Results:

    • Embolic occlusions, particularly from platelet-fibrin thrombi, cholesterol crystals, and calcific particles, are a primary cause of TMVL.
    • Retinal vasoconstriction represents another significant etiology.
    • Anterior ischemic optic neuropathy, papilledema, optic disk drusen, and colobomas are less common but relevant causes.

    Conclusions:

    • Effective management of transient monocular visual loss hinges on accurate etiological diagnosis.
    • Understanding embolic sources and composition is critical for risk stratification and treatment.
    • A comprehensive approach considering both ophthalmic and systemic factors is essential for addressing TMVL.